Showing results (31-40 of 73) with videos related to
Sort By:
Pageof 8
The Journal of Urology|October 31, 2006
Daily intravesical instillation of 1 mg nociceptin/orphanin FQ for the control of neurogenic detrusor overactivity: a multicenter, placebo controlled, randomized exploratory studyMassimo Lazzeri, Girolamo Calò, Michele Spinelli, et al.British Journal of Pharmacology|September 19, 2002
A new ligand for the urotensin II receptorValeria Camarda, Remo Guerrini, Evi Kostenis, et al.American Journal of Physiology. Heart and Circulatory Physiology|February 15, 2003
Chronic effects of angiotensin-converting enzyme inhibition on kinin receptor binding sites in the rat spinal cordBrice Ongali, Hudson de Sousa Buck, Frank Cloutier, et al.Urology|May 9, 2003
Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: a randomized, placebo-controlled, double-blind studyMassimo Lazzeri, Girolamo Calò, Michele Spinelli, et al.American Journal of Physiology. Heart and Circulatory Physiology|October 10, 2006
Characterization and localization of Ac-SDKP receptor binding sites using 125I-labeled Hpp-Aca-SDKP in rat cardiac fibroblastsJia L Zhuo, Oscar A Carretero, Hongmei Peng, et al.Journal of Peptide Science : an Official Publication of the European Peptide Society|January 7, 2005
Structure-activity relationship study on human urotensin IIRemo Guerrini, Valeria Camarda, Erika Marzola, et al.CNS Drug Reviews|July 12, 2005
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptorGirolamo Calo, Remo Guerrini, Anna Rizzi, et al.Peptides|July 27, 2005
Hypotensive effects of hemopressin and bradykinin in rabbits, rats and mice. A comparative studyPaul-André Blais, Jérôme Côté, Josée Morin, et al.Regulatory Peptides|November 4, 2008
The non-peptide kinin receptor antagonists FR 173657 and SSR 240612: preclinical evidence for the treatment of skin inflammationEvelise Fernandes Pietrovski, Michel Fleith Otuki, Domenico Regoli, et al.The Journal of Pharmacology and Experimental Therapeutics|March 3, 2007
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studiesAnna Rizzi, Elaine C Gavioli, Giuliano Marzola, et al.Pageof 8